ATHE

Alterity Therapeutics-ADR Cross-source read$4.05 1.46%
Health CareCUSIP 02155X205· EOD Sep 11, 2026

Among active 13F managers last quarter, 1 opened and 3 added, while none reduced or exited; the largest holder to move was Citadel Advisors LLC (+87%). Over the last 180 days, 1 insider bought and none sold, a net +$24K in open-market trades.

Tracked 13F holders
17
10 in Q2 2026 filings
13F value (tracked)
$1.6M
Smart-money readBullish
Net sellingNet buying
Funds · active managers, latest 13F
4 adding · 0 trimming
Insiders · Form 4 open-market, 180d
1 buying · 0 selling · +$24K
US House · STOCK Act, 180d
0 buying · 0 selling

Funds lean in and no leg opposes.

Price & smart-money activity

$4.05 1.46%5Y -67.9%
$0.11$3.60$7.09$10.57$14.062021202220232024202520262322253224
Hover for who · click for detailEnd-of-day closing prices52w $2.92 – $5.89

Who owns ATHE?

17 tracked 13F filers · ranked by shares held

17 tracked 13F filers disclose a position in ATHE as of the latest SEC 13F filings, a combined $1.6M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

#FundSharesPosition valueLast moveAs ofHistory
1Twin Lakes Capital Management, LLC139K
$748K
Held
Q2 2026
2HB Wealth Management, LLC58K
$314K
Held
Q2 2026
3Morgan Stanley58K
$203K
−8.3%
Reduced · −5K sh
Q1 2026
4Citadel Advisors LLC38K
$202K
+87%
Added · +18K sh
Q2 2026
5Greenleaf Trust32K
$111K
Held
Q1 2026
6BNP Paribas Financial Markets7K
$24K
−1.4%
Reduced · −100 sh
Q1 2026
7GAMMA Investing LLC2K
$12K
+24%
Added · +453 sh
Q2 2026
8Rhumbline Advisers2K
$7K
−7.4%
Reduced · −157 sh
Q1 2026
9Providence Capital Advisors, LLC200
$1K
Added
Added · +200 sh
Q2 2026
10Osaic Holdings, Inc.68
$240
−16%
Reduced · −13 sh
Q1 2026
11Blue Trust, Inc.40
$215
Held
Q2 2026
12Farther Finance Advisors, LLC22
$80
Held
Q1 2026
13CoreCap Advisors, LLC21
$73
Held
Q1 2026
14Steward Partners Investment Advisory, LLC6
$32
Held
Q2 2026
15Cranbrook Wealth Management, LLC1
$6
New
+1 sh
Q2 2026
16Danske Bank A/s1
$5
Held
Q2 2026
17Caitong International Asset Management Co., Ltd1
$5
New
+1 sh
Q2 2026

Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.

Is ATHE being bought or sold by institutions?

Last quarter, 1 fund opened a new position in ATHE and 3 added to an existing one, while none reduced or exited. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).

Opened
1
fund took a first position
Added
3
added to an existing position
Biggest moves · ranked by size of the change, positions above a floor

Funds that own ATHE also own

CompanyCo-held byTheir position there
Nvidia CorpNVDA9 funds$2.9B
Amazon.com IncAMZN9 funds$2.9B
Apple IncAAPL9 funds$2.8B
Alphabet Inc-CL AGOOGL9 funds$1.3B
Eli Lilly & CoLLY9 funds$1.3B
Alphabet Inc-CL CGOOG9 funds$1.2B
Advanced Micro DevicesAMD9 funds$1.0B
JPMorgan Chase & CoJPM9 funds$873.0M
Abbott LaboratoriesABT9 funds$804.5M
Mastercard Inc - AMA9 funds$799.7M
Coca-Cola CoKO9 funds$746.6M
Berkshire Hathaway Inc-CL BBRK/B9 funds$720.3M

Ranked by how many of ATHE's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in ATHE.

Insider activity (Form 4)

Full insider page →
Buys · 180d
$24K
1 insider
Net · 180d
$24K
1 open-market transaction
DateInsiderRoleActionSharesValue
Aug 31, 2026Marks Peter AshleyDirectorBuy (P)48K$24K

Do institutions, insiders and Congress agree?

Confluence: insiders and funds buying

Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.

SEC EDGAR 13F + Form 4 + US House STOCK Act{ }get_ticker_confluence · API & MCP

Signals by source

Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive

SourceBuyingSellingNet
13F funds
Top 100 holders by value, passive included; the hero counts active managers only
34
Insiders
Form 4 open-market
10+$24K
US House
STOCK Act trades
00$0
Sector rotation
ATHE is in Health Care, which smart money is rotating OUT OF
$5.0B

Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.

Institutional ownership over time

10 tracked filers in Q2 2026 filingsstill filing
0816Q3 2024Q1 2025Q3 2025Q1 2026Q2 2026
tracked filers holding their reported valueQ2 2026 filings so far: $1.3M
Each bar counts tracked filers with a position in that quarter's filings, so the newest bar excludes filers still on an earlier quarter. Arkolith's tracked universe has grown over this window; part of any long-run rise is coverage, not new buyers.

Recent filings

4 most recent

Keep exploring

Connected entities for ATHE

Browse more

Build

Ask your agent what changed in ATHE

This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.

Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/stocks/ATHE/capital-change-brief"
Ask your agent
Use Arkolith's capital_change_brief for ATHE.
Tell me what changed, whether insider activity
corroborates it, and cite the SEC evidence.

13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for ATHE. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.